CLINICAL_TRIALS
trial_result
· 2021-01-25
Clinical Trial Update: The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation [Phase 2]
Summary
Phase 2 trial update for AdAPT Adenovirus after allogeneic pediatric transplantation; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Jazz Pharmaceuticals | Conditions: Adenovirus | Phase 2 | Status: TERMINATED | Results posted: 2021-01-25